738P Strong tumour cytidine deaminase (CDA) staining predicts for improved survival associated with sequential nab-paclitaxel (nabP) and gemcitabine (GEM) chemotherapy as first line treatment of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC).
Corrie, P Qian, W Gopinathan, A Williams, M Brais, R Basu, B Falk, S Iwuji, C Wasan, H
Corrie, P
Qian, W
Gopinathan, A
Williams, M
Brais, R
Basu, B
Falk, S
Iwuji, C
Wasan, H
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
738P Strong tumour cytidine deaminase (CDA) staining predicts for improved survival associated with sequential nab-paclitaxel (nabP) and gemcitabine (GEM) chemotherapy as first line treatment of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC). 2017, 28(suppl_5): Ann Oncol